Skip to main content

Greenwich LifeSciences, Inc.

GLSI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001799788

In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Greenwich LifeSciences, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of GLSI: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders2324+1
Shares628.8K537.4K−91.4K (−14.5%)
Value$6.06M$4.75M−$1.31M (−21.7%)

New holders (2)

Institutions that held Greenwich LifeSciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to GLSI in Q3 2023
InstitutionSharesValue% of portfolio
Squarepoint Ops LLC10,970$97.0K0.00%
Qube Research & Technologies Ltd1,310$11.6K0.00%

Sold out (1)

Institutions that held Greenwich LifeSciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of GLSI in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
HRT Financial LP10,136$97.0K